[1] Dei Cas A, Gnudi L. VEGF and angiopoietins in diabetic glomerulopathy:how far for a new treatment[J]. Metabolism, 2012, 61(12):1666-1673. [2] 曹延萍, 王莎, 刘杰, 等. 线粒体凋亡途径在高糖刺激的小鼠足细胞凋亡中的作用[J]. 中国应用生理学杂志, 2013, 29(3):244-246. [3] Patrakka J, Tryggvason K. Nephrin——a unique structural and signaling protein of the kidney filter[J]. Trends Mol Med, 2007, 13(9):396-403. [4] Roy S, Metya SK, Sannigrahi S, et al. Treatment with ferulic acid to rats with streptozotocin-induced diabetes:effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell[J]. Endocrine, 2013, 44(2):369-379. [5] 连加辨,吴枝娟,方秋娟,等. 阿魏酸钠对幼大鼠心肌柔红霉素损伤的保护作用. 中国应用生理学杂志,2015, 31(1):54-58. [6] Choi R, Kim BH, Naowaboot J, et al. Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes[J]. Exp Mol Med, 2011, 43(12):676-683. [7] Doublier S, Salvidio G, Lupia E, et al. Nephrin expression is reduced in human diabetic nephropathy:evidence for a distinct role for glycated albumin and angiotensin Ⅱ[J]. Diabetes, 2003, 52(4):1023-1030. [8] Baelde HJ, Eikmans M, Lappin DW, et al. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss[J]. Kidney Int, 2007, 71(7):637-645. [9] Prabhakar PK, Prasad R, Ali S, et al. Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats[J]. Phytomedicine, 2013, 20(6):488-494. [10] Ramar M, Manikandan B, Raman T, et al. Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice[J]. Eur J Pharmacol, 2012, 690(1-3):226-235. |